セファランチン水塩化物は,腸内微生物群と代謝物質を調節することにより,前立腺がんの進行を阻害する
Hui Li1, Xing Luo2, Peng He1,3
1Department of Ultrasound, Second Affiliated Hospital, Army Medical University, Chongqing, China.
Frontiers in pharmacology
|August 29, 2025
まとめ
セファランチン塩化物 (CH) は腸内微生物群を調節することによって前立腺がんの成長を抑制する. この効果は腸内細菌が枯渇すると失われ,前立腺がんのCH治療における微生物群の重要な役割を強調しています.
科学分野:
- 腫瘍学
- 微生物学
- 薬理学について
背景:
- セファランチン水塩化物 (CH) は,白血病の治療に臨床的に使用されます.
- 前立腺がんの進行と腸内微生物群の作用は不明である.
研究 の 目的:
- 前立腺がんの増殖に対するCHの抑制効果を調査する.
- この効果が腸内微生物群によって媒介されているかどうかを判断する.
主な方法:
- 前立腺がんのマウスモデルが確立され,抗生物質の予備治療が行われた.
- マウスはCH治療を受け,その後腫瘍の大きさを測定した.
- 排泄物,血液,腫瘍組織は16S rDNA,メタボロミクス,およびトランスクリプトミクスを使用して分析された.
主要な成果:
- CHは正常なマウスの前立腺がんの増殖を抑制したが,抗生物質を投与したマウスは抑制しなかった.
- CHは腸内微生物の組成を変えて有益な細菌を増やし アッケルマンシアを減少させました
- 関連分析により,CHは特定の微生物,代謝,遺伝子発現の変化によって癌を抑制することが示唆された.
結論:
- この研究は,前立腺がんの腸内微生物媒介によるCH治療のメカニズムを明らかにしています.
- 前立腺がんの治療にCHを使用するための科学的根拠を提供します.
関連する概念動画
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
395
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
395
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
201
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
201
Drugs for Treatment of Diarrhea-Predominant IBS
292
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
292
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
366
Drugs for Treatment of Constipation-Predominant IBS
326
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
326
What is Monogastric Digestion?
72.5K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
72.5K


